Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3702183 | 1.00 | RET (0.45) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL3702180 | 1.00 | RET (0.45) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL4411047 | 0.80 | RET (0.46) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL14325015 | 0.78 | MAPK14 (0.49) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL8991557 | 0.78 | RET (0.45) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL9426196 | 0.78 | RET (0.49) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL8316378 | 0.78 | RET (0.45) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL596246 | 0.78 | RET (0.53) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL177080 | 0.78 | MAPK14 (0.49) | RETMAPK14CAMK1DHDAC6TBXA2R | |
| SCHEMBL2811047 | 0.78 | MAPK14 (0.49) | RETMAPK14CAMK1DHDAC6TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | PROCTER & GAMBLE (US) | 2020-05-14 | — | — | US | claimed |
| US-10568825-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-02-25 | — | — | US | claimed |
| US-20170267944-A1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-21 | — | — | US | claimed |
| US-20150322376-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-11-12 | — | — | US | claimed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| US-20140179748-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMAPNY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-12636240-B2 | Antiperspirant composition | COTY INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12533302-B2 | Systems and methods for delivery of actives and healing tissue | VIAS PARTNERS, LLC | 2026-01-27 | — | — | US | disclosed |
| EP-4304548-B1 | ANTIPERSPIRANT COMPOSITION | COTY INC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20240299262-A1 | ANTIPERSPIRANT COMPOSITION | COTY INC. | 2024-09-12 | — | — | US | disclosed |
| US-20240252424-A1 | ANTIPERSPIRANT COMPOSITION | COTY INC. | 2024-08-01 | — | — | US | disclosed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | disclosed |
| US-5800897-A | Air freshener composition containing a fiber pad | EASTMAN CHEMICAL COMPANY (US) | 1998-09-01 | — | — | US | disclosed |
| WO-1997026926-A1 | AIR FRESHENER COMPOSITION CONTAINING A FIBER PAD | EASTMAN CHEMICAL COMPANY (US) | 1997-07-31 | — | — | WO | disclosed |
| US-4283347-A | Para-menth-1-ene-7-sulfonic acid and salts thereof | SCM CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4224240-A | Preparation of para-menth-1-ene-7-sulfonate salts and corresponding acids | SCM CORPORATION (US) | 1980-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568825-B2 | Antiperspirant and deodorant compositions | DEK, QDPR, GPX4 | RET 3101/4885MAPK14 2454/4885CAMK1D 4671/4885 |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | RET 3101/4885MAPK14 2454/4885CAMK1D 4671/4885 |
| US-12533302-B2 | Systems and methods for delivery of actives and healing tissue | EXOSC10, PDGFA, EXOSC9 | RET 4145/4885MAPK14 2477/4885CAMK1D 3197/4885 |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | RET 3101/4885MAPK14 2454/4885CAMK1D 4671/4885 |
| US-12636240-B2 | Antiperspirant composition | OPRD1, DRD2, TAS2R40 | RET 2770/4885MAPK14 2320/4885CAMK1D 3717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.